DEFA14A: Monogram Updates Shareholders on Zimmer Biomet Acquisition

Monogram Technologies Inc. informed stockholders via text message about updated FAQs regarding its proposed acquisition by Zimmer Biomet Holdings, Inc.

Summary

• Monogram Technologies Inc. (MGRM) issued a text message to its stockholders on July 31, 2025.
• The text directed stockholders to the Frequently Asked Questions (FAQs) section on the company's Investor Relations page.
• These FAQs pertain to the previously announced proposed acquisition of Monogram by Zimmer Biomet Holdings, Inc.
• The acquisition was initially announced on July 14, 2025.

Sentiment

Score: 6

Explanation: The filing is a procedural update on a previously announced acquisition, indicating ongoing progress and proactive shareholder communication, which is generally positive for transparency. It contains no new negative information.

Positives

• Proactive communication with stockholders regarding the proposed acquisition.
• Availability of detailed FAQs on the Investor Relations page to address stockholder queries.

Risks

• Information furnished in this Current Report on Form 8-K is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, limiting liability.
• Information is not deemed incorporated by reference into any other filing under the Exchange Act or Securities Act of 1933, unless expressly stated.

Future Outlook

The company is progressing with the proposed acquisition by Zimmer Biomet Holdings, Inc., and is providing ongoing communication to stockholders regarding this significant corporate event.

Management Comments

• "Monogram Acquisition by Zimmer Biomet FAQs Available Here:"

Industry Context

Consolidation through mergers and acquisitions is a common trend in the medical technology and device industry, driven by the pursuit of market share, technological synergies, and operational efficiencies. This communication indicates the ongoing process of a significant M&A event within this sector.

Comparison to Industry Standards

• NA

Stakeholder Impact

• Shareholders: Provided with updated information and resources (FAQs) regarding the proposed acquisition, which could lead to a change in ownership and potential payout.
• Management/Employees: Implied ongoing work related to the acquisition process and integration planning.

Next Steps

• Continued process towards the proposed acquisition by Zimmer Biomet Holdings, Inc.
• Stockholders are directed to the FAQs for ongoing information.

Key Dates

Keywords

Monogram Technologies, Zimmer Biomet, Acquisition, Merger, MGRM, Healthcare Technology, Medical Devices, SEC Filing, 8-K, Shareholder Communication